Gil Wolfe

Research activity per year

Fingerprint

Dive into the research topics where Gil Wolfe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Active
9 Finished

State University of New York (SUNY) NEXT Clinical Site
Sawyer, R. (CoI), Wolfe, G. (CoI), Sawyer, R. (CoI), Wolfe, G. (CoI), Levine, S. (PI), Coyle, P. (CoI), Jubelt, B. (CoI) & Shefner, J. (CoI)
National Inst of Neurological Disorders & Stroke
09/1/13 → …
University at Buffalo
Project: Research
State University of New York (SUNY) NEXT Clinical Site
Sawyer, R. (CoI), Wolfe, G. (CoI), Sawyer, R. (CoI), Wolfe, G. (CoI), Levine, S. (PI), Coyle, P. (CoI), Jubelt, B. (CoI) & Shefner, J. (CoI)
National Inst of Neurological Disorders & Stroke
09/1/12 → …
University at Buffalo
Project: Research
State University of New York (SUNY) NEXT Clinical Site
Wolfe, G. (CoI), Wolfe, G. (CoI), Levine, S. (PI), Coyle, P. (CoI), Mejico, L. (CoI), Coyle, P. (CoI), Levine, S. (PI), Mejico, L. (CoI) & Wolfe, G. (CoI)
National Inst of Neurological Disorders & Stroke
07/1/21 → 06/30/22
University at Buffalo, Stony Brook University, Upstate Medical University, SUNY Downstate Health Sciences University
Project: Research
State University of New York (SUNY) NEXT Clinical Site
Coyle, P. (CoI), Levine, S. (PI), Mejico, L. (CoI) & Wolfe, G. (CoI)
National Inst of Neurological Disorders & Stroke
07/1/20 → 06/30/21
Stony Brook University, University at Buffalo, SUNY Downstate Health Sciences University, Upstate Medical University
Project: Research
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of ARGX-113 in Patients with Myasthenia Gravis Having Generalized Muscle Weakness
Wolfe, G. (PI)
Syneos Health LLC
06/12/19 → 06/12/21
University at Buffalo
Project: Research

112 Article
39 Review article
10 Letter
9 Editorial
More

Urinary dysfunction in myasthenia Gravis: a cross-sectional case-control study
Shihada, K., Gorenshtein, A., Wolfe, G. I. & Shelly, S., Jan 2026, In: Neurological Sciences. 47, 1, 91.
University at Buffalo
Research output: Contribution to journal › Article › peer-review

Open Access
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity
Dewilde, S., Qi, C. Z., De Ruyck, F., Paci, S., Van de Veire, L., Griffiths, A., Wolfe, G. I., Mantegazza, R. & Phillips, G., 2025, In: Frontiers in Public Health. 13, 1538789.
University at Buffalo
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Myasthenia Gravis-Redemption for B-Cell Depletion
Wolfe, G. I. & Shelly, S., Jun 19 2025, In: New England Journal of Medicine. 392, 23, p. 2382-2384 3 p.
University at Buffalo
Research output: Contribution to journal › Editorial
2 Scopus citations
National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel
Shelly, S., Gotkine, M., Wilf Yarkoni, A., Lotan, I., Abraham, A., Dori, A., Wolfe, G. I., Regev, K., Vaknin, A. & Ben-Hur, T., Jan 1 2025, In: Therapeutic Advances in Neurological Disorders. 18, 17562864251361607.
University at Buffalo
Research output: Contribution to journal › Review article › peer-review

Open Access
4 Scopus citations
Ocular myasthenia gravis management
Kupersmith, M. J., Wolfe, G. I. & Kaminski, H., 2025, In: Frontiers in Neurology. 16, 1678151.
University at Buffalo
Research output: Contribution to journal › Short survey › peer-review

Open Access

Gil Wolfe

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

State University of New York (SUNY) NEXT Clinical Site

State University of New York (SUNY) NEXT Clinical Site

State University of New York (SUNY) NEXT Clinical Site

State University of New York (SUNY) NEXT Clinical Site

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of ARGX-113 in Patients with Myasthenia Gravis Having Generalized Muscle Weakness

Urinary dysfunction in myasthenia Gravis: a cross-sectional case-control study

A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity

Myasthenia Gravis-Redemption for B-Cell Depletion

National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel

Ocular myasthenia gravis management

Gil Wolfe

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output